Skip to main content

Table 1 Demographic, clinical and outcome data of 143 patients with differing therapy-modifying recommendations by ASP and ID physicians

From: Antimicrobial stewardship auditing of patients reviewed by infectious diseases physicians in a tertiary university hospital

 

ASP recommendation accepted

ID physician recommendation accepted

p-value

(n= 100)

(n= 43)

Median age, years (interquartile range)

64 (53ā€“72)

58 (50 ā€“ 72)

0.393

Intensive care unit admission within 30 days prior to review (%)

23 (23.0)

10 (23.3)

0.973

Median Charlson Comorbidity Index (interquartile range)

5 (3 ā€“ 8)

5 (2 ā€“ 8)

0.255

Clinical discipline (%)

  

0.754

ā€¢ Hematology-oncology

36 (36.0)

12 (27.9)

 

ā€¢ Surgery

29 (29.0)

12 (27.9)

 

ā€¢ Orthopedics

24 (24.0)

13 (30.2)

 

ā€¢ Medicine

10 (10.0)

6 (14.0)

 

ā€¢ Others

1 (1.0)

0 (0)

 

Type of infection (%):

  

0.247

ā€¢ Intra-abdominal infection

23 (23.0)

9 (20.9)

 

ā€¢ Bloodstream

12 (12.0)

6 (14.0)

 

ā€¢ Bone and joint infection

14 (14.0)

12 (27.9)

 

ā€¢ Skin and soft tissue infection

15 (15.0)

6 (14.0)

 

ā€¢ Respiratory tract infection

6 (6.0)

2 (4.7)

 

ā€¢ Urinary tract infection

10 (10.0)

6 (14.0)

 

ā€¢ Othersa

20 (20.0)

2 (4.7)

 

Type of ASP recommendations:b

  

0.172

ā€¢ Discontinue antibiotics

26

5

 

ā€¢ De-escalate antibiotics

30

16

 

ā€¢ Escalate antibiotics

8

5

 

ā€¢ Intravenous to oral antibiotic switch

6

2

 

ā€¢ Dose optimization

16

5

 

ā€¢ Duration of antibiotics

0

2

 

ā€¢ Discontinue duplicate antibiotic coverage

9

7

 

ā€¢ Other recommendationsc

10

3

 

Outcomes (%):

   

ā€¢ 30-day mortality

7 (7.0)

3 (7.0)

1.000

ā€¢ 30-day re-admissiond

21 (22.6)

6 (15.0)

0.358

ā€¢ Clinical deterioration

8 (8.0)e

12 (27.9)f

0.003

ā€ƒā—‹ Persistent fever

2 (25.0)

4 (33.3)

 

ā€ƒā—‹ No microbiological clearance

2 (25.0)

3 (25.0)

 

ā€ƒā—‹ Lack of physiological improvement

6 (75.0)

10 (83.3)

 
  1. a"Others" include undifferentiated fevers, viral infections, and no infection.
  2. bThere were 150 ASP recommendations for 143 patients.
  3. c"Other recommendations" include switching to less expensive carbapenems (9 cases), streamlining antibiotics (2 cases) and addition of antifungal agents (2 cases).
  4. dPatients who had died are excluded.
  5. eOne patient had persistent fever and bacteremia; one patient had persistent fever with hypotensive episodes; one patient had persistent candidemia with respiratory distress.
  6. fTwo patients had persistent fever and persistent positive wound cultures; one patient had persistent fever and bacteremia with cardiac failure; one patient had persistent fever with hypotension.